[1] Jessup M,Brozena S.Heart failure.N Engl J Med,2003,348(20):2007-2018.
[2] Yan W,Wu F,Morser J,et al.Corin,a transmembrane cardiac serine protease,acts as a pro-atrial natriuretic peptide-converting enzyme.Proc Natl Acad.Sci.USA,2000,97(15):8525-8529.
[3] Armaly Z,Assady S,Abassi Z.Corin:a new player in the regulation of salt-water balance and blood pressure.Curr Opin Nephrol Hypertens,2013,22(6):713-722.
[4] Chan J C,Knudson O,Wu F,et al.Hypertension in mice lacking the proatrial natriuretic peptide convertase corin.Proc Natl Acad Sci USA,2005,102(3):785-790.
[5] Cui Y J,Wang W,Dong N Z,et al.Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy.Nature,2012,484(7393):246-250.
[6] Wang W,Shen J Z,Cui Y J,et al.Impaired sodium excretion and salt-sensitive hypertension in corin-deficient mice.Kidney Int,2012,82(1):26-33.
[7] Dries D L,Victor R G,Rame J E,et al.Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension.Circulation,2005,112(16):2403-2410.
[8] Dong N Z,Chen S H,Yang J H,et al.Plasma soluble corin in patients with heart failure.Circ Heart Fail,2010,3(2):207-211.
[9] Dong N Z,Dong J,Liu P,et al.Effects of anticoagulants on human plasma soluble corin levels measured by ELISA.Clin Chim Acta,2010,411(23-24):1998-2003.
[10] Ibebuogu U N,Gladysheva I P,Houng A K,et al.Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide.Circ Heart Fail,2011,4(2):114-120.
[11] Yan W,Sheng N,Seto M,et al.Corin,a mosaic transmembrane serine protease encoded by a novel cDNA from human heart.J Biol Chem,1999,274(21):14926-14935.
[12] Wu Q Y,Cai O,Chen S H,et al.Corin:new insights into the natriuretic peptide system.Kidney Int,2009,75(2):142-146.
[13] Chen S H,Cao P X,Dong N,et al.PCSK6-mediated corin activation is essential for normal blood pressure.Nat Med,2015,21(9):1048-1053.
[14] Wang W,Cui Y J,Shen J Z,et al.Salt-sensitive hypertension and cardiac hypertrophy in transgenic mice expressing a corin variant identified in blacks.Hypertension,2012,60(5):1352-1358.
[15] Gladysheva I P,Wang D,McNamee R A,et al.Corin overexpression improves cardiac function,heart failure,and survival in mice with dilated cardiomyopathy.Hypertension,2013,61(2):327-332.
[16] Dong N Z,Fang C D,Jiang Y Z,et al.Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment.J Biol Chem,2013,288(11):7867-7874.
[17] Zhang Y,Li H,Zhou J P,et al.A corin variant identified in hypertensive patients that alters cytoplasmic tail and reduces cell surface expression and activity.Sci Rep,2014,4:7378.
[18] Colucci W S,Elkayam U,Horton D P,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated congestive heart failure.Nesiritide Study Group.N Engl J Med,2000,343(4):246-253.
[19] Anker S D,Ponikowski P,Mitrovic V,et al.Ularitide for the treatment of acute decompensated heart failure:from preclinical to clinical studies.Eur Heart J,2015,36(12):715-723.
[20] Mitaka C,Kudo T,Haraguchi G,et al.Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients:a systematic review and meta-analysis.Crit Care,2011,15(5):R258.
[21] Saito Y.Roles of atrial natriuretic peptide and its therapeutic use.J Cardiol,2010,56(3):262-270.
[22] Ohashi M,Fujio N,Nawata H,et al.Pharmacokinetics of synthetic alpha-human atrial natriuretic polypeptide in normal men;effect of aging.Regul Pept,1987,19(5-6):265-272.
[23] Nakao K,Sugawara A,Morii N,et al.The pharmacokinetics of alpha-human atrial natriuretic polypeptide in healthy subjects.Eur J Clin Pharmacol,1986,31(1):101-103.
[24] Vanneste Y,Pauwels S,Lambotte L,et al.In vivo metabolism of brain natriuretic peptide in the rat involves endopeptidase 24.11 and angiotensin converting enzyme.Biochem Biophys Res Commun,1990,173(1):265-271.
[25] Nour N,Mayer G,Mort J S,et al.The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.Mol Biol Cell,2005,16(11):5215-5226.
[26] Mains R E,Berard C A,Denault J B,et al.PACE4:a subtilisin-like endoprotease with unique properties.Biochem J,1997,321(Pt 3):587-593.
[27] Barr P J.Mammalian subtilisins:the long-sought dibasic processing endoproteases.Cell,1991,66(1):1-3.
[28] Seidah N G,Chretien M.Proprotein and prohormone convertases:a family of subtilases generating diverse bioactive polypeptides.Brain Res,1999,848(1-2):45-62. |